Semicarbazide-cadmium therapy, also known as the Kachugin method, was an experimental cancer therapy tested in several clinical trials in the Soviet Union during the 1960s, devised by the Russian physician and chemist Anatoly Trofimovich Kachugin. Semicarbazide acts as an irreversible inhibitor of the enzyme semicarbazide-sensitive amine oxidase, which may be involved in worsening inflammation, while cadmium is a heavy metal capable of inducing cell death by apoptosis.
Facts
Classification
StatusDiscontinued or Obsolete 1 Connections
Treats
Source Semicarbazide-cadmium therapy (Wikipedia)
Source Semicarbazide-cadmium therapy (Wikipedia)
Source Semicarbazide-cadmium therapy (Wikipedia)
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundationhttps://en.wikipedia.org/wiki/Semicarbazide-cadmium_therapy, lead sectionQuote, https://en.wikipedia.org/wiki/Semicarbazide-cadmium_therapy, lead section
Semicarbazide-cadmium therapy, also known as the Kachugin method, was an experimental cancer therapy that was tested in several clinical trials in the Soviet Union during the 1960s.
Semicarbazide-cadmium therapy (Wikipedia)
Treats: Cancer, Lead: treats Cancer
This method was successfully used for treatment of patients in later stages of lung, intestinal, and breast cancer, melanoma, and some other cancer types.
Treats: Melanoma, Lead: treats Melanoma
This method was successfully used for treatment of patients in later stages of lung, intestinal, and breast cancer, melanoma, and some other cancer types.
Treats: Breast Cancer, Lead: treats Breast Cancer
This method was successfully used for treatment of patients in later stages of lung, intestinal, and breast cancer, melanoma, and some other cancer types.
View the SourceReader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.